About
PDC Therapeutics is a biotechnology start-up developing targeted Polymer-Drug Conjugate technologies that aim to provide patients with an optimal therapeutic index. PDC Therapeutics’ proprietary Sagitta® biodegradable conjugation platforms help discover and develop therapies with no compromise with a versatile targeting capability. Cooperating with multinational pharmaceutical companies through co-development programs, PDC Therapeutics is supported by an industry-experienced board of scientific and supervisory experts around the world.
Details
- Tagline:
- Biotechnology start-up advancing clinically-valiated platform technology Sagitta® for polymer-drug conjugates.
- Industry:
- Biotechnology Research
- Company size:
- 2-10
- Headquarters:
- Lausanne
- Org type:
- Privately Held
- Founded:
- 2020
- Specialties:
- biotechnology
- Follower count:
- 829
- Employee count:
- 6
